PATIENT ALERT: Masks are now optional in our VOA offices. If you are immunocompromised or feeling ill, masking is strongly encouraged. CLICK HERE for more details.
CLICK HERE regarding the Change Healthcare update.

Clinical Research & Trials

USO 22166

Phase 1/2 Safety and Efficacy Study of NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors (NUV-868-01)

Disease Types: Solid Tumors Research

Available at:

Norfolk (Brock Cancer Center)

Treatment Options

Services

Support During Cancer

Cancers We Treat

Blood Cancers

Blood Disorders

Find a Provider Near You

Clinical Research & Trials

Listen to our podcast

USO 22166

Phase 1/2 Safety and Efficacy Study of NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors (NUV-868-01)